exercise Placebo-Controlled Trials of Pediatric Patients (10 to 17 years) with Bipolar Mania Treated with Oral Abilify Percentage of Patients Reporting Reaction Abilify Placebo Preferred Term (n=197) (n=97) Somnolence 23 3 Extrapyramidal Disorder 20 3 Fatigue 11 4 Nausea 11 4 Akathisia 10 2 Blurred Vision 8 0 Salivary Hypersecretion 6 0 Dizziness 5 1 Pediatric Patients (6 to 17 years) with Autistic Disorder The following findings are based on two 8-week prompted
possibly ia (incidence of 5% or greater and Abilify incidence at least twice that for placebo) are shown in Table 19 . Table 19: Commonly Observed Adverse Reactions in Short-Term seem
EmoticonEmoticon